TFThiago Francischetto

Thiago Francischetto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thiago Francischetto has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Radiofrequency ablation versus surgical resection as first-line treatment for very early stage hepatocellular carcinoma: a systematic review with meta-analysis

    by Eduardo Freitas Viana, Diego Falcão Araújo, Thiago Francischetto Ribeiro, Vaner Paulo da Silva Fonseca Pinheiro, Rodrigo Leal Alves, André Luiz Aleluia da Silva, Helma Pinchemel Cotrim, André Castro Lyra

  • Open Access

    Influência da biopsia de linfonodo sentinela no prognóstico de pacientes com melanoma acral

    by Thiago Francischetto, Ana Clara Falcão, Adson Santos Neves, Ana Beatriz Lira, Robson Freitas de Moura, Thiago Souza Oliveira Freitas de Moura, Juvandy Antonio Inacio Santos, André Bacellar Costa Lima, Marco Antonio Oliveira Lessa, Jussamara Britos Santos, et al.

  • Open Access

    Influence of sentinel lymph node biopsy on the prognosis of acral melanoma patients

    by Thiago Francischetto, Ana Clara Falcão, Adson Santos Neves, Ana Beatriz Lira, Robson Freitas de Moura, Thiago Souza Oliveira Freitas de Moura, Juvandy Antonio Inacio Santos, André Bacellar Costa Lima, Marco Antonio Oliveira Lessa, Jussamara Britos Santos, et al.

  • Open Access

    EARLY POSTOPERATIVE OUTCOMES OF THE ESOPHAGECTOMY MINIMALLY INVASIVE IN ESOPHAGEAL CANCER

    by Thiago Francischetto, Vaner Paulo da Silva Fonseca Pinheiro, Eduardo Freitas Viana, Eduardo Dias de Moraes, Bruno Mendonça Protásio, Marco Antônio Oliveira Lessa, Gustavo Lousado de Almeida, Victor Rivera Duran Barretto, Alexandre Farias de Albuquerque

    BACKGROUND: The incidence of esophageal cancer is high in some regions and the surgical treatment requires reference centers, with high volume, to make surgery feasible. AIMS: To evaluate patients undergoing minimally invasive esophagectomy by thoracoscopy in prone position for the treatment of esophageal cancer and to recognize the experience acquired over time in our service after the introduction of this technique. METHODS: From January 2012 to August 2021, all patients who underwent the minimally invasive esophagectomy for esophageal cancer were retrospectively analyzed. In order to assess the factors associated with the predefined outcomes as fistula, pneumonia, and intrahospital death, we performed univariate and multivariate logistic regression analyses, accounting for age as an important factor. RESULTS: Sixty-six patients were studied, with mean age of 59.5 years. The main histological type was squamous cell carcinoma (81.8%). The incidence of postoperative pneumonia and fistula was 38% and 33.3%, respectively. Eight patients died during this period. The patient's age, T and N stages, the year the procedure was performed, and postoperative pneumonia development were factors that influenced postoperative death. There was a 24% reduction in the chance of mortality each year, associated with the learning curve of our service. CONCLUSIONS: The present study presented the importance of the team's experience and the concentration of the treatment of patients with esophageal cancer in reference centers, allowing to significantly improve the postoperative outcomes.


  • Influence of Sentinel Lymph Node Tumor Burden on Survival in Melanoma

    by Thiago Francischetto, Nelson Spector, Jose Francisco Neto Rezende, Marcelle de Azevedo Antunes, Sergio de Oliveira Romano, Isabele A. Small, Carlos Gil Ferreira

    Completion lymph node dissection (CLND) is the standard procedure for patients with positive sentinel lymph nodes (SLN). With extensive pathological workup, increased numbers of small metastatic deposits are detected in SLN. This study evaluated the prognostic significance of SLN metastatic deposits < or = 0.2 mm in patients treated in a referral cancer center in Brazil. Patients with stage I/II melanoma, consecutively submitted to a SLN procedure by the same surgeon from 2000 to 2006, were evaluated. All positive SLN and randomly selected negative cases were reviewed by two pathologists. Different prognostic factors and SLN tumor burden were recorded. Additional positive non-SLN after CLND, and disease outcome were evaluated. Of 381 patients who underwent SLN biopsy, 103 (27%) were positive. The mean/median Breslow tumor thickness in the overall group was 3.4/2.0 mm and in the SLN positive patients was 5.72/4.0 mm. Among these patients, 48 (47%) had metastatic deposits >2 mm (macrometastasis), 49 (47%) had metastatic deposits < or =2 mm but >0.2 mm (micrometastasis), and 6 (6%) had metastatic deposits < or =0.2 mm (submicrometastasis). Additional positive non-SLN were detected in 29% of patients with macrometastasis, in 25% of patients with micrometastasis, and in 0% of patients with submicrometastases. At median follow-up of 35 months, the estimated 3-year overall survival was 92% for negative SLN, 64% for micrometastases, 53% for macrometastases, and 100% for submicrometastases (P < 0.001). In the present study, patients with SLN metastatic deposits < or =0.2 mm had no additional positive non-SLNs, and no recurrences or deaths were recorded, suggesting that their prognosis is equivalent to that of patients with negative SLN.


      • Vol. 52
    Open Access

    Gastric cancer treatment in Brazil: a multicenter study of the Brazilian Gastric Cancer Association

    by Marcus Fernando Kodama Pertille Ramos, Marina Alessandra Pereira, Thiago Francischetto Ribeiro, Oddone Braghiroli, Felipe José Fernandez Coimbra, Marco Antônio Gonçalves Rodrigues, Flavio Duarte Sabino, Ulysses Ribeiro, Ronaldo Mafia Cuenca, Felipe Carvalho Victer, et al.

    Gastric cancer (GC) has distinct characteristics and management according to the region of the world, and the objective of our study was to evaluate how it is being managed in Brazil. This is a multicenter study that involved 18 oncology referral centers. Data were collected using the REDCap platform and compiled at the end of one year. All Brazilian regions were represented, and 635 patients were included. Most patients were from the Southeast (40.6%) and Northeast (29.6%) regions. The mean age was 62 years, with a predominance of males. Most patients (84.6%) had good performance status, with an ECOG score of 1-2. Less than 10% of patients were covered by medical insurance. A quarter of the patients underwent diagnostic laparoscopy, but endoscopic ultrasound and PET scans were rarely performed. The cT3 category was the most common (40.6%), lymph node involvement was described in 48.9%, and distant metastases, in 14.4% of the staging exams. The final cTNM staging was III (29.4%), II (26%), I (24.2%) and IV (20.5%). Most patients underwent surgery with curative intent (74.4%) and open access (82.8%). Preoperative chemotherapy was performed in 37.2% of cases, and the most common surgical procedures were subtotal gastrectomy (45.3%) and total gastrectomy (33.1%). The present study allowed us to evaluate the current panorama of surgical treatment of Gastric Cancer, representing all regions of Brazil. Stage III, distal, and diffuse tumors continue to be prevalent in Brazil, and there has been relevant use of diagnostic laparoscopy, preoperative chemotherapy, and minimally invasive surgery.